Endpoints News· Kyle LaHucik·· 3 小时前AI 评分42
Setara 获 9000 万美元，推进从 Jazz 收购 Actio 交易中分拆的罕见病管线
Setara gets $90M to continue rare disease pipeline spun out of Jazz's Actio deal
AI 导读
Setara 获得 9000 万美元融资，用于推进从 Actio Biosciences 分拆出的遗传学驱动罕见病管线。Actio 此前已将精准癫痫药物出售给 Jazz Pharmaceuticals，其余管线随之剥离为 Setara。
正文 · 原文
After shipping its precision epilepsy drug to Jazz Pharmaceuticals, Actio Biosciences has spun out the remainder of its genetics-driven pipeline into a new company called …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源：Endpoints News · endpoints.news